Oncolytics Today Fall 2025
Published Date: October 14, 2025
7 | ONE BIG BEAUTIFUL BILL ACT: New reforms may not be so beautiful for oncology practices and patients. Download
11 | BUSINESS BEHIND ONCOLOGY: Navigating payers, partnerships and the financial landscape. Download
15 | ARTIFICIAL INTELLIGENCE: The near-term potential of AI remains shrouded in regulatory uncertainty. Download
19 | DRUG PRICING UNDER IRA: New laws promise relief, but will pose a challenge for pharma and patients. Download
23 | MEDICARE PART D MAZE: Education is the key to helping your patients understand the new rules. Download
26 | A BETTER MODEL FOR ONCOLOGY: Experts make the case for expanding OOLD in preference to other distribution models. Download
29 | NGS THERAPY REVIEW: The latest recommendations for NSCLC, colorectal, breast and prostate cancers. Download
37 | THE CHALLENGE OF REMS: IMiD prescription management and the role of the pharmacist. Download
43 | ADVANCES IN ALK INHIBITION: New therapies, resistance mechanisms and emerging strategies in NSCLC. Download
50 | PROSTATE CANCER: Imaging and therapy options from an oncology perspective. Download
54 | A NOVEL SCORING FRAMEWORK: Analyzing and improving access pathways to oral oncology therapies. Download
57 | FINDING FINANCIAL ASSISTANCE: How PAN Foundation helps cancer patients. Download
67-71 | INPATIENT TO OUTPATIENT: A look at how multiple practices are evolving CAR-T, BsAbs & BiTES therapy. Download
76 | BsAbs RECOMMENDATIONS: Tear-out charts for lymphoma, multiple myeloma and other disease states. Download Tear Chart.
84 | PHARMACOGENOMICS: UCSF launches PGx program to enhance safety for gastrointestinal cancer patients. Download
87 | ENHANCING ABIRATERONE: Case series on the effect of low-dose and low-fat diet on the drug’s cost and efficacy. Download
93 | LOVE ON LIFE’S TERMS: Finding the language to support one another during the cancer journey. Download
96 | RAPID TRIAL ACTIVATION: Implications and opportunities for investigational drug service operations. Download
98 | CLINICAL TRIAL CHALLENGES: Improving enrollment through trust and patient-centric development. Download
101-108 | GLOBAL PERSPECTIVE: International oncology reviews and reports from Brazil, Morocco and Japan. Download
117 | THE ROAD WARRIOR: New Jersey pharmacist bike-a-thon rider goes that extra mile for his patients. Download
To Request The Oncolytics Today Media Kit / Rate Card, Contact: partnership@ncoda.org
- Two issues in Spring (March) and Fall (October)
- Audience includes 10,000+ Oncology and Urology health professionals
- Print and digital formats available
- Multi-ad discounts available
Read Past Editions
Oncolytics Today
Oncolytics Today Spring 2025
A New Way to Treat Brain Cancer? A Phase 1 clinical trial explored the use of Rhenium (186Re) Obisbemeda (186RNL) for treating recurrent glioma, demonstrating its potential to deliver high radiation doses with minimal toxicity. The promising results, particularly in patients receiving higher doses, set the stage for further evaluation in Phase 2 trials.
April 21, 2025
Oncolytics Today
Oncolytics Today Fall 2024
THE BISPECIFIC ANTIBODY REVOLUTION: Breakthroughs in research have led to a host of new cellular therapies. In this issue of Oncolytics Today, we take a look at recently approved BsAbs as well as advances in tumor-infiltrating lymphocytes, antibody-drug conjugates and CAR-T therapy.
October 1, 2024
Oncolytics Today
Oncolytics Today Spring 2024
Filling the Diversity Gap in Cancer Care: Racial inequity in healthcare, particularly in oncology, has been well-documented. Bringing equity to charitable copay assistance and better communication across diverse healthcare teams offer opportunities to improve the situation.
April 1, 2024
Oncolytics Today
Oncolytics Today Fall 2023
Oncology Faces a Host of Rising Challenges: NCODA takes a hard look at the oncology drug shortage, the Stark Law’s impact on prescription mailing, alternative funding programs, the Inflation Reduction Act and 340B abuse.
October 1, 2023
Oncolytics Today
Oncolytics Today Spring 2023
Empower the medically integrated oncology pharmacy practice.
April 1, 2023
Oncolytics Today
Oncolytics Today Fall 2022
Targeting breast cancer a possible paradigm shift in HER2 therapy, new role of TKIs, clinical updates, integrating the ASCO/NCODA Patient-Centered Standards and archery as therapy.
October 1, 2022